---

$4.54

-0.2650 ( -5.52% ) 254.2K

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-03-06	Sale	-26056.00	Myers Laurie
2024-03-06	Sale	-16676.00	Brams Matthew
2024-03-06	Sale	-1824.00	Werth Peter J.
2024-03-06	Sale	-5000.00	ROBERTS JOHN A
2024-03-06	Sale	-57323.00	Schaffer Shane J.
2024-01-29	Sale	-687043.00	Werth Peter J.
2024-01-02	Sale	-1000.00	Silva Raul R.
2023-10-02	Sale	-10000.00	Silva Raul R.
2023-09-18	Buy	5000.00	Callahan Jennifer L.
2023-09-11	Sale	-6838235.00	Werth Peter J.